Hospira Drug Shortage Suit Must Be Revived, 11th Circ. Told

Law360, Washington (January 4, 2013, 8:03 PM EST) -- A putative class of individuals affected by Hospira Inc.'s decision to stop producing an injectable vitamin supplement on Thursday urged the Eleventh Circuit to revive their suit, alleging other companies may stop producing life-saving drugs if they don't face the threat of similar litigation.

In July, a Florida federal judge tossed the complaint over shortages of the vitamin A medicine called Aquasol A with prejudice, determining it would improperly intrude on Hospira's business prerogatives. But the plaintiffs told the appeals court they should have been allowed to...
To view the full article, register now.